Terremoto Biosciences
CA - South SFBiotechnology
Focus: Terremoto Biosciences is a public biotech company focused on covalent small molecule therapeutics in oncology and neurology. The company is in early-stage development with a minimal clinical footprint.
Profile data last refreshed 15h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
1
Should You Work at Terremoto Biosciences?
AI assessmentTerremoto is a high-risk, speculative bet suitable only for scientists seeking deep technical work in covalent chemistry; career visibility and growth are severely constrained by minimal hiring and early-stage maturity.
Why Work Here
- Focused therapeutic modality (covalent small molecules) offers deep specialization opportunity in a differentiated mechanism — valuable expertise in a competitive market
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
PHASE_1
Clinical Trials (1)
NCT07255846A Trial of TER-1754 in Patients With Hereditary Hemorrhagic Telangiectasia
Phase 1Help build intelligence for Terremoto Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.